OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
Anuradha Budhu, Erica C. Pehrsson, Aiwu Ruth He, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101052-101052
Open Access | Times Cited: 14
Anuradha Budhu, Erica C. Pehrsson, Aiwu Ruth He, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101052-101052
Open Access | Times Cited: 14
Showing 14 citing articles:
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 77
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 77
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy
Keyan Miao, Weici Liu, Jingtong Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Keyan Miao, Weici Liu, Jingtong Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Lineage and ecology define liver tumor evolution in response to treatment
Mahler Revsine, Limin Wang, Marshonna Forgues, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101394-101394
Open Access | Times Cited: 3
Mahler Revsine, Limin Wang, Marshonna Forgues, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101394-101394
Open Access | Times Cited: 3
Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort
Katharina Mitzlaff, Martha M. Kirstein, Christian Müller, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
Katharina Mitzlaff, Martha M. Kirstein, Christian Müller, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy
Valentina Zanuso, Lorenza Rimassa, Chiara Braconi
Hepatology (2023)
Closed Access | Times Cited: 3
Valentina Zanuso, Lorenza Rimassa, Chiara Braconi
Hepatology (2023)
Closed Access | Times Cited: 3
Immunogenomics of cholangiocarcinoma
Virag Gehl, Colm J. O’Rourke, Jesper B. Andersen
Hepatology (2023)
Closed Access | Times Cited: 2
Virag Gehl, Colm J. O’Rourke, Jesper B. Andersen
Hepatology (2023)
Closed Access | Times Cited: 2
Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives
Caiyi Cherry Li, Meng Liu, Hsin-Pei Lee, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 133-146
Closed Access
Caiyi Cherry Li, Meng Liu, Hsin-Pei Lee, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 133-146
Closed Access
Radio-immunomics in hepatocellular carcinoma: Unraveling the tumor immune microenvironment
Qianyun Liu, Wenwei Zhu, Fulong Song, et al.
Meta-Radiology (2024) Vol. 2, Iss. 3, pp. 100098-100098
Open Access
Qianyun Liu, Wenwei Zhu, Fulong Song, et al.
Meta-Radiology (2024) Vol. 2, Iss. 3, pp. 100098-100098
Open Access
HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis
Yanzhu Chen, Zhishang Meng, Zuo‐Lin Xiang
Frontiers in Immunology (2024) Vol. 15
Open Access
Yanzhu Chen, Zhishang Meng, Zuo‐Lin Xiang
Frontiers in Immunology (2024) Vol. 15
Open Access
Lean Management and use of AI in healthcare: living in the present
Giulio Polimeni, Roberto Adrower
Medical Academy Journal (2024) Vol. 3, Iss. 1, pp. 9-9
Open Access
Giulio Polimeni, Roberto Adrower
Medical Academy Journal (2024) Vol. 3, Iss. 1, pp. 9-9
Open Access
NFS1 as a Candidate Prognostic Biomarker for Gastric Cancer Correlated with Immune Infiltrates
You Jiang, Wenbo Li, Jun Zhang, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 3855-3868
Open Access
You Jiang, Wenbo Li, Jun Zhang, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 3855-3868
Open Access
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J. Park, Milan Parikh, Leon Pappas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ryan J. Park, Milan Parikh, Leon Pappas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access
